ÂÒÂ×Ðã

To acknowledge 10 years of operation in 2021, weÌýput together a review of our achievements to celebrate all things TRO - from funding successes, drug discoveries and project progressions from preclinical to clinical, to spin out contributions and the development of long-term industry relationships.Ìý

We also highlight how our vision and values in the areas of Research, Innovation and Education contribute to wider ÂÒÂ×Ðã goals and how we will continue to build on an increasingly vibrant translational culture over the next 10 years. Ìý

Jane Kinghorn, Director at ÂÒÂ×Ðã Translational Research Office and Nick McNally, Managing Director Research ÂÒÂ×Ðã/ÂÒÂ×ÐãH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.Ìý

Jane Kinghorn, ÂÒÂ×Ðã TRO DirectorÌýand Anne Lane, CEO at ÂÒÂ×Ðã Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at ÂÒÂ×Ðã and their partner hospitals.

Translational education and training for early career researchers

In this interview, Colby Benari, Head of the Academic Careers Office (ACO) at ÂÒÂ×Ðã, discusses the role and impact of the ÂÒÂ×Ðã ACO and highlights new translational training opportunities for Early Career Researchers.Ìý

Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office)Ìýat ÂÒÂ×Ðã, explain the value of drug discovery in academia in bridging the "Valley of Death".

The innovation game

Professor David Lomas discusses the Therapeutic Innovation Networks (TINs), which are facilitating and accelerating enterprise at University College London (ÂÒÂ×Ðã),

Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from ÂÒÂ×Ðã, argue that the ability to listen and learn makes ÂÒÂ×Ðã a global partner of choice for health research and innovation.Ìý

Translating novel science to patient benefit

Dr Jane Kinghorn discusses how University College London (ÂÒÂ×Ðã)’s Translational Research Office (TRO) is working to encourage, facilitate and contribute to the translation of ÂÒÂ×Ðã’s and its partner hospitals’ research.

Cell, Gene and Regenerative Therapies at ÂÒÂ×Ðã and NHS Partner Trusts

ÂÒÂ×Ðã in partnership with our three NIHR BRCs at University College London Hospital (ÂÒÂ×ÐãH), Great Ormond Street Hospital for Children (GOSH) and Moorfields Eye Hospital (MEH) are world leaders in the development and delivery to patients of novel cell, gene and regenerative therapies.Ìý

ÂÒÂ×Ðã supporting Healthcare Leadership and Innovation capacity building in Africa

In late 2018, ÂÒÂ×Ðã’s Academic Careers Office (ACO) and Translational Research Office (TRO) along with ÂÒÂ×Ðã partner the Africa Health Research Institute (AHRI), were successful in applying for a UKRI Global Challenge Research Fund Impact Acceleration Award (GCRF IAA).ÌýThe ACO and TRO organised two events in South Africa open to participants from across the African continent.